Hyo S. Han, Patricia LoRusso, Erika P. Hamilton, Noelia Martinez-JaƱez, Valentina Boni, Rodrigo Sanchez-Bayona, Carlo Palmieri, Anne C. Armstrong, Elisa Fontana, Geoff Fisher, Sue Brook, Hendrik-Tobias Arkenau, Joyce O'Shaughnessy. "Results of a phase 1 study of vosilasarm (EP0062), a first-in-class oral selective androgen receptor modulator (SARM) in patients with advanced or metastatic AR+/ER+/HER-2- breast cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1057